H9F

2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol

Created:2020-12-04
Last modified:  2021-12-08

Find related ligands:

Chemical Details

Formal Charge0
Atom Count76
Chiral Atom Count0
Bond Count79
Aromatic Bond Count11
2D diagram of H9F

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Chemical Component Summary

Name2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
Systematic Name (OpenEye OEToolkits)2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
FormulaC24 H40 N8 O4
Molecular Weight504.626
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO
SMILESOpenEye OEToolkits2.0.7C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO
Canonical SMILESCACTVS3.385 OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO
Canonical SMILESOpenEye OEToolkits2.0.7 C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO
InChIInChI1.03 InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
InChIKeyInChI1.03 IZEKFCXSFNUWAM-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00975 
NameDipyridamole
Groups approved
DescriptionA phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Synonyms
  • Dypyridamol
  • Dipyridamole
  • Dipyudamine
  • Dipiridamol
  • Dipyridamine
Brand Names
  • Aspirin and Extended-release Dipyridamole
  • Persantine
  • Novo-dipiradol Tab 50mg
  • Dipyridamole 50 Tab 50mg
  • Aggrenox
IndicationFor as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
Categories
  • Anticoagulants
  • Antiplatelet agents
  • Blood and Blood Forming Organs
  • BSEP/ABCB11 Substrates
  • Cardiovascular Agents
ATC-CodeB01AC07
CAS number58-32-2

Drug Targets

NameTarget SequencePharmacological ActionActions
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AMASLEEPLAPRPQGPLPAAGDEPGCGPGKLRPEPRLSAAGGGSAAGPGPA...unknowninhibitor
cGMP-specific 3',5'-cyclic phosphodiesteraseMERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKAT...unknowninhibitor
3',5'-cyclic-AMP phosphodiesterase 4AMEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD...unknowninhibitor
Adenosine deaminaseMAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVI...unknowninhibitor
Calcipressin-1MEDGVAGPQLGAAAEAAEAAEARARPGVTLRPFAPLSGAAEADEGGGDWS...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL932
PubChem 3108
ChEMBL CHEMBL932
ChEBI CHEBI:4653